RUSSO, Diego
 Distribuzione geografica
Continente #
NA - Nord America 7.071
AS - Asia 5.104
EU - Europa 1.631
SA - Sud America 1.197
AF - Africa 111
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 15.131
Nazione #
US - Stati Uniti d'America 6.800
SG - Singapore 2.364
CN - Cina 1.238
BR - Brasile 926
IT - Italia 704
VN - Vietnam 592
IN - India 476
SE - Svezia 292
GB - Regno Unito 190
DE - Germania 172
CA - Canada 167
AR - Argentina 109
BD - Bangladesh 98
HK - Hong Kong 68
MX - Messico 61
FI - Finlandia 59
EC - Ecuador 57
TR - Turchia 56
ID - Indonesia 40
IQ - Iraq 30
RU - Federazione Russa 30
ZA - Sudafrica 28
UA - Ucraina 25
ES - Italia 24
NL - Olanda 24
CO - Colombia 22
PY - Paraguay 22
IR - Iran 18
PK - Pakistan 18
PL - Polonia 18
JP - Giappone 17
CL - Cile 16
MA - Marocco 16
RO - Romania 15
VE - Venezuela 15
FR - Francia 14
DZ - Algeria 13
EE - Estonia 13
UY - Uruguay 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
KE - Kenya 11
PE - Perù 11
DO - Repubblica Dominicana 10
TN - Tunisia 10
IE - Irlanda 9
JM - Giamaica 9
ET - Etiopia 8
SA - Arabia Saudita 8
BO - Bolivia 7
GR - Grecia 7
JO - Giordania 7
AU - Australia 6
IL - Israele 6
KR - Corea 6
AT - Austria 5
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
HN - Honduras 5
SY - Repubblica araba siriana 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BE - Belgio 4
GT - Guatemala 4
SV - El Salvador 4
BG - Bulgaria 3
BH - Bahrain 3
DK - Danimarca 3
EU - Europa 3
HR - Croazia 3
KZ - Kazakistan 3
NG - Nigeria 3
NP - Nepal 3
PA - Panama 3
PH - Filippine 3
SN - Senegal 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
KG - Kirghizistan 2
LB - Libano 2
MD - Moldavia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AL - Albania 1
BB - Barbados 1
BY - Bielorussia 1
GN - Guinea 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MG - Madagascar 1
Totale 15.119
Città #
San Jose 1.237
Chandler 778
Dallas 662
Singapore 594
Ashburn 588
Santa Clara 421
Hefei 373
Bengaluru 372
Lawrence 360
Princeton 360
Milan 355
Ho Chi Minh City 220
Wilmington 197
Chicago 153
Beijing 152
London 146
Hanoi 121
Munich 120
Ottawa 119
Des Moines 118
São Paulo 76
Hong Kong 67
Boardman 66
Shanghai 58
Los Angeles 52
Turku 46
Council Bluffs 43
Catanzaro 42
New York 40
Haiphong 38
Norwalk 37
Rio de Janeiro 33
Guangzhou 29
Da Nang 28
Shenzhen 25
Brooklyn 23
Redwood City 22
Mexico City 21
Pune 21
Rome 21
Chennai 20
Guayaquil 19
Curitiba 18
Quito 18
San Francisco 18
Thái Bình 18
Hanover 17
Istanbul 17
Brasília 15
Jiaxing 15
Montreal 15
Belo Horizonte 14
Ninh Bình 14
Porto Alegre 14
Seattle 14
Washington 14
Ankara 13
Atlanta 13
Campinas 13
Johannesburg 13
Biên Hòa 12
Orem 12
Redmond 12
Toronto 12
Baghdad 11
Delhi 11
Helsinki 11
Manaus 11
Phoenix 11
Salvador 11
Tokyo 11
Warsaw 11
Boston 10
Buffalo 10
Dhaka 10
Horia 10
Montevideo 10
Nairobi 10
Stockholm 10
Ann Arbor 9
Fortaleza 9
Hortolândia 9
Hải Dương 9
Jakarta 9
Quanzhou 9
Tashkent 9
Xi'an 9
Abu Dhabi 8
Bauru 8
Buenos Aires 8
Catania 8
Guarulhos 8
Nottingham 8
Ribeirão Preto 8
Rui'an 8
Santo André 8
The Dalles 8
Voghera 8
Wuhan 8
Wuxi 8
Totale 8.928
Nome #
Biological Activity of Oleuropein and Its Derivatives 182
Liposomes as multicompartmental carriers for multidrug delivery in anticancer chemotherapy 119
Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer 91
Lipoamino Acid Prodrugs of Paclitaxel: Synthesis and Cytotoxicity Evaluation on Human Anaplastic Thyroid Carcinoma Cells 89
Anti-hTERT siRNA-loaded nanoparticles block the growth of anaplastic thyroid cancer xenograft 89
Antiproliferative Effects of Cynaropicrin on Anaplastic Thyroid Cancer Cells 87
Precision oncology for RET-related tumors 86
A case of metastatic medullary thyroid carcinoma: early identification before surgery of a ret proto-oncogene somatic mutation in fine needle aspirate specimen 86
Impact of legumes and plant proteins consumption on cognitive performances in the elderly 84
A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC 83
Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases 82
Hashimoto's thyroiditis and vestibular dysfunction 81
A novel mutation in the thyrotropin receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistence to TSH 80
Antiproliferative effects afforded by pyrazolopyrimidine derivates on human neuroblastoma cells 80
Antiproliferative activity of PDE5 inhibitors vehicled by nanovescicles in thyroid cancer cells. 79
Antioxidant and antigrowth action of peracetylated oleuropein in thyroid cancer cells 79
IL-20 Subfamily Biological Effects: Mechanistic Insights and Therapeutic Perspectives in Cancer 78
A Phe 486 TSH receptor mutation in a autonomously functioning follicular carcinoma that was causing hyperthyroidism 77
A thyroid follicular cancer presenting as a hot nodule and hyperfunctioning because of an activating mutation of the TSH receptor 77
A case of anaplastic Diffuse Large B-Cell Thyroid Lymphoma: unique immunophenotype and unusual clinical presentation 77
A novel mutation in the Thyrotropin receptor gene causing loss of TSH binding but constitutive activation in a family with resistance to TSH 76
A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH 76
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: Functional characterization 75
Anti-hTERT siRNA nanoparticles block the growth of anaplastic thyroid cancer cells in vitro and in vivo. 75
Absence od Sodium/Iodide symporter gene mutations in differentiated human thyroid carcinomas 74
A hyperfunctioning Hurtle cell thyroid carcinoma with a mutation in the thyrotropin receptor 74
A Val 677 activating mutation of the Thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis 74
Antiproliferative and antioxidant effects of oleuropein and its semisynthetic peracetylated derivatives on breast cancer cells 73
Association between low C-peptide and fragility fractures in postmenopausal women without diabetes 72
Activating mutations of the TSH Receptor in differentiated thyroid carcinomas 70
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with pheochromocytoma and medullary thyroid carcinoma: Functional characterization 69
A case of metastatic medullary thyroid carcinoma: Early identification before surgery of an RET proto-oncogene somatic mutation in fine-needle aspirate specimens 68
A Val677 activating mutation of the thyrotropin receptor in a Hurtle cell thyroid carcinoma associated with thyrotossicosis 67
TSH-CONJUGATED NANOCARRIER FOR THE TREATMENT OF THYROID CANCER 66
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma. 66
Antiproliferative Effects of Two Pyrazolo-Pyrimidine Derivates on Human Anaplastic Thyroid Cancer Cells 66
Expression and cellular localization of Ref-1 in human thyroid carcinoma cell lines 65
Adenyl cyclase activity and Gs and Gi alpha ADP-ribosylation in thyroid hyperfunctioning adenomas presenting TSH receptor or Gsp mutations 65
Antiproliferative activity of PDE5 inhibitors vehicled by nanovesicles in thyroid cancer cells 65
Effects of Oleacein on High-Fat Diet-Dependent Steatosis, Weight Gain, and Insulin Resistance in Mice 65
A new structural model for the Thyrotropin receptor as determined by covalent crosslinking of Thyrotropin to the recombinant receptor in intact cells: evidence for a single polypeptide chain. 64
Antioxidant and antiproliferative effects of olive-leaf extract oleuropein and its peracetylated derivate on human thyroid cancer cells 64
A call to action: Now is the time to screen elderly and treat osteosarcopenia, a position paper of the italian college of academic nutritionists med/49 (ican-49) 64
Evaluation of biological effects of TERT inhibition in human thyroid cancer cells 63
A novel germline VHL gene mutation in two different patients with pheochromocytoma. 63
Antiproliferative activity of PDE5 inhibitors vehicle by nanovesicles in thyroid cancer cells. 63
Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells 62
Absence of iodide symporter gene mutations in human thyroid tumors 62
Epigenetic-related gene expression profile in Medullary Thyroid Cancer revealed the overexpression of the Histone methyltransferases EZH2 and SMYD3 in aggressive tumours. 62
Carcinomi differenziati della tiroide: ruolo oncogenico del recettore del TSH 60
Antiproliferative effects of olive-leaf extract oleuropein and derivatives in human breast cancer cells 60
A Val677 activating mutation of the thyrotropin receptor in a Hürtle cell thyroid carcinoma associated with thyrotoxicosis 57
Analisi della proteina APE/Ref-1 nei noduli tiroidei iperfunzionanti: aumento dell’espressione nelle frazioni nucleari 57
APE/Ref-1 is increased in nuclear fractions of human thyroid hyperfunctioning nodules 57
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: Biodistribution, pharmacokinetic features and in vivo antitumor activity 57
MicroRNAs as Biomarkers in Thyroid Carcinoma 56
NANOVETTORE CONIUGATO CON TSH PER IL TRATTAMENTO DEL CANCRO DELLA TIROIDE 56
Vestibular disorders in euthyroid patients with Hashimoto’s thyroiditis: role of thyroid autoimmunity. 56
Ape1/Ref-1 is increased in nuclear fractions of human thyroid hot nodules 55
Functional interaction among thyroid specific transcription factors: PAX8 regulates the activity of Hex promoter 55
Functional analysis of the cytoplasmic domains of the human TSH receptor by site-directed mutagenesis. 55
Carcinoma midollare della tiroide: identificazione di una nuova mutazione 55
Prohibitin is overexpressed in papillary thyroid carcinomas bearing the BRAFV600E mutation 54
Genetic analysis in fine needle aspiration of the thyroid: a new tool for clinic 54
Expression of adenylyl cyclase types III and VI in human hyperfunctioning thyroid nodules 54
Oleacein inhibits STAT3, activates the apoptotic machinery, and exerts anti-metastatic effects in the SH-SY5Y human neuroblastoma cells 54
Expression of YAP1 in aggressive thyroid cancer 54
Maggisano V., Capriglione F., Mio C., Bulotta S., Damante G., Russo D., Celano M 53
Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches. 53
Expression and localization of the sodium/iodide symporter (NIS) in testicular cells 53
Alterazioni del trasportatore dello iodio in patologia tiroidea 53
An activating mutation in the thyrotropin receptor causing thyrotoxicosis in a Hurtle cell thyroid carcinoma 53
High periostin expression correlates with aggressiveness in papillary thyroid carcinomas 53
Normocaloric Diet Restores Weight Gain and Insulin Sensitivity in Obese Mice 53
Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomes. 53
Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer. 53
A synonymous RET substitution enhances the oncogenic effect of an in-cis missense mutation by increasing constitutive splicing efficiency. 52
Dihydrotanshinone exerts antitumor effects and improves the effects of cisplatin in anaplastic thyroid cancer cells 52
Eleven amino acids (Lys-201 to Lys-211) and 9 amino acids (Gly-222 to Leu-230) in the human thyrotropin receptor are involved in ligand binding. 51
Control of PTEN gene expression in normal and neoplastic thyroid cells 51
Expression of leptin receptor and effects of leptin on papillary thyroid carcinoma cells 51
Genetica molecolare delle tireopatie 51
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells 51
Safety Evaluation of Subchronic Oral Administration of Oleuropein and its Semisynthetic Peracetylated Derivative 51
Co-Encapsulation of Paclitaxel and JQ1 in Zein Nanoparticles as Potential Innovative Nanomedicine 50
Identification of thyroid-associated serum microrna profiles and their potential use in thyroid cancer follow-up 50
BRAF V600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas 50
Aqueous–core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response 50
Analysis of YAP1 expression in papillary thyroid cancer, lymph node metastases and medullary thyroid cancer. 50
A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism 50
Expression of miR-31-5p affects growth, migration and invasiveness of papillary thyroid cancer cells 49
Absence of Sodium-Iodide Symporter gene mutations in differentiated human thyroid carcinomas 49
Different molecular mechanisms are involved in the multihormonal control of glucose transport in FRTL-5 rat thyroid cells 49
APE/Ref-1 is increased in nuclear fractions of human thyroid hyperfuctioning nodules 49
Secretome Analysis of Hypoxia-Induced 3T3-L1 Adipocytes Uncovers Novel Proteins Potentially Involved in Obesity 49
B-RAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism 49
Identification of novel molecular target for the treatment of thyroid cancers. 49
Detection of an activating mutation of the TSH receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma 49
Genetic analysis in fine needle aspiration biopsy of the thyroid: a new tool for the clinic. 49
Quercetin improves the effects of sorafenib on growth and migration of thyroid cancer cells. 49
Totale 6.437
Categoria #
all - tutte 163.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 163.760


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 0 0 0 0 0 0 33
2021/2022873 4 3 7 185 117 11 37 210 80 59 147 13
2022/20232.398 738 98 73 186 246 204 5 174 351 135 146 42
2023/2024834 164 142 57 43 49 229 13 36 16 17 12 56
2024/20253.321 551 316 155 180 123 415 24 87 450 286 227 507
2025/20267.348 243 925 961 1.549 686 222 837 503 830 377 157 58
Totale 15.312